| Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial SE Nissen, EM Tuzcu, P Schoenhagen, BG Brown, P Ganz, RA Vogel, ... Jama 291 (9), 1071-1080, 2004 | 3507 | 2004 |
| Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial SE Nissen, T Tsunoda, EM Tuzcu, P Schoenhagen, CJ Cooper, M Yasin, ... Jama 290 (17), 2292-2300, 2003 | 2270 | 2003 |
| European guidance for the diagnosis and management of osteoporosis in postmenopausal women JA Kanis, N Burlet, C Cooper, PD Delmas, JY Reginster, F Borgstrom, ... Osteoporosis international 19, 399-428, 2008 | 1465 | 2008 |
| Stenting and medical therapy for atherosclerotic renal-artery stenosis CJ Cooper, TP Murphy, DE Cutlip, K Jamerson, W Henrich, DM Reid, ... New England Journal of Medicine 370 (1), 13-22, 2014 | 1158 | 2014 |
| Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison CJ Cooper, RA El-Shiekh, DJ Cohen, L Blaesing, MW Burket, A Basu, ... American heart journal 138 (3), 430-436, 1999 | 834 | 1999 |
| Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic … R Lozano, N Fullman, D Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 2091-2138, 2018 | 536 | 2018 |
| Guidelines for the reporting of renal artery revascularization in clinical trials JH Rundback, D Sacks, KC Kent, C Cooper, D Jones, T Murphy, ... Journal of vascular and interventional radiology 14 (9), S477-S492, 2003 | 521 | 2003 |
| Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the … CJ Cooper, TP Murphy, A Matsumoto, M Steffes, DJ Cohen, M Jaff, ... American heart journal 152 (1), 59-66, 2006 | 382 | 2006 |
| Repositioning of the global epicentre of non-optimal cholesterol Nature 582 (7810), 73-77, 2020 | 244 | 2020 |
| Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans CJ Cooper, MJ Landzberg, TJ Anderson, F Charbonneau, MA Creager, ... Circulation 93 (2), 266-271, 1996 | 221 | 1996 |
| Renal-artery stenosis LD Dworkin, CJ Cooper New England Journal of Medicine 361 (20), 1972-1978, 2009 | 215 | 2009 |
| A radiographic atlas of osteoarthritis S Burnett, DJ Hart, C Cooper, TD Spector London: Springer-Verlag, 1994 | 209 | 1994 |
| Renal artery angioplasty and stent placement: predictors of a favorable outcome MW Burket, CJ Cooper, DJ Kennedy, PS Brewster, GM Ansel, JA Moore, ... American heart journal 139 (1), 64-71, 2000 | 196 | 2000 |
| X-linked mixed deafness with congenital fixation of the stapedial footplate and perilymphatic gusher. WE Nance, R Setleff, A McLeod, A Sweeney, C Cooper, F McConnell Birth defects original article series 7 (4), 64-69, 1971 | 196 | 1971 |
| Embolic protection and platelet inhibition during renal artery stenting CJ Cooper, ST Haller, W Colyer, M Steffes, MW Burket, WJ Thomas, ... Circulation 117 (21), 2752-2760, 2008 | 194 | 2008 |
| The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK C Cooper, M Steinbuch, R Stevenson, R Miday, NB Watts Osteoporosis international 21, 569-577, 2010 | 190 | 2010 |
| ACTN3 genotype, athletic status, and life course physical capability: meta‐analysis of the published literature and findings from nine studies T Alfred, Y Ben‐Shlomo, R Cooper, R Hardy, C Cooper, IJ Deary, ... Human mutation 32 (9), 1008-1018, 2011 | 189 | 2011 |
| Common variants at 12q15 and 12q24 are associated with infant head circumference HR Taal, B St Pourcain, E Thiering, S Das, DO Mook-Kanamori, ... Nature genetics 44 (5), 532-538, 2012 | 162 | 2012 |
| Stent fracture in the coronary and peripheral arteries S Adlakha, M Sheikh, J Wu, MW Burket, U Pandya, W Colyer, E Eltahawy, ... Journal of interventional cardiology 23 (4), 411-419, 2010 | 153 | 2010 |
| New firms in the biotechnology industry: their contribution to innovation and growth. R Oakey, W Faulkner, C Cooper, V Walsh | 150 | 1990 |
